Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beenu Thakral

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|March 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletionsEitan Kugler, Enes Dasdemir, Alex Bataller, et al.
JCO Precision Oncology|May 17, 2023
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in <i>ABL</i> Class RearrangementsJayastu Senapati, Elias Jabbour, Marina Konopleva, et al.
American Journal of Hematology|April 7, 2020
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group studyHeesun J Rogers, Xiaoqiong Wang, Yan Xie, et al.
American Journal of Clinical Pathology|April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group studyGenevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
Human Pathology|January 7, 2022
Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activationSofia Garces, L Jeffrey Medeiros, Mario Luiz Marques-Piubelli, et al.
Cancers|November 13, 2021
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and ManagementRichard K Yang, Gokce A Toruner, Wei Wang, et al.
British Journal of Haematology|May 23, 2019
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapyHaitham Khogeer, Haitham Rahman, Nitin Jain, et al.
Virchows Archiv : an International Journal of Pathology|March 2, 2023
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variantSiba El Hussein, L Jeffrey Medeiros, Stephen K Gruschkus, et al.
Blood Advances|October 26, 2022
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLLNitin Jain, Jayastu Senapati, Beenu Thakral, et al.
American Journal of Hematology|April 10, 2019
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk diseaseAndrés E Quesada, Mark J Routbort, Courtney D DiNardo, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|March 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletionsEitan Kugler, Enes Dasdemir, Alex Bataller, et al.
JCO Precision Oncology|May 17, 2023
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in <i>ABL</i> Class RearrangementsJayastu Senapati, Elias Jabbour, Marina Konopleva, et al.
American Journal of Hematology|April 7, 2020
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group studyHeesun J Rogers, Xiaoqiong Wang, Yan Xie, et al.
American Journal of Clinical Pathology|April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group studyGenevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
Human Pathology|January 7, 2022
Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activationSofia Garces, L Jeffrey Medeiros, Mario Luiz Marques-Piubelli, et al.
Cancers|November 13, 2021
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and ManagementRichard K Yang, Gokce A Toruner, Wei Wang, et al.
British Journal of Haematology|May 23, 2019
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapyHaitham Khogeer, Haitham Rahman, Nitin Jain, et al.
Virchows Archiv : an International Journal of Pathology|March 2, 2023
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variantSiba El Hussein, L Jeffrey Medeiros, Stephen K Gruschkus, et al.
Blood Advances|October 26, 2022
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLLNitin Jain, Jayastu Senapati, Beenu Thakral, et al.
American Journal of Hematology|April 10, 2019
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk diseaseAndrés E Quesada, Mark J Routbort, Courtney D DiNardo, et al.
Pageof 10